Avalo Therapeutics, Inc. · NASDAQ:AVTX

Caligan Partners LP's stake in Avalo Therapeutics, Inc. fell to 4.90% (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 17, 2026

Caligan Partners LP's stake in Avalo Therapeutics, Inc. fell to 4.90%, 881,533 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).

Stake
4.90%
Shares
881,533
Intent
Passive
What changed
Fell below 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Caligan Partners LP4.90%881,533
David Johnson4.90%881,533

Source

View original at SEC

Related